FDA considers ‘regulatory action’ for bluebird’s Skysona after blood cancer reports
December 2, 2024RFK Jr. could ‘cost lives in this country’ if he pursues changes to US vaccine policy, Gottlieb says
December 2, 2024After temporary reprieve, Advanz Pharma’s liver med Ocaliva loses marketing nod in Europe
fkansteiner
Mon, 12/02/2024 – 14:33
